Tirzepatide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists and is a GIP. By targeting both receptors, Tirzepatide enhances insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control. In addition to its glucose-lowering effects, Tirzepatide has been associated with significant weight loss in clinical trials.
What’s Included:
Includes
Telehealth Visit (optional), Tirzepatide
Sunday | Closed |
---|---|
Monday | 5pm - 8pm |
Tuesday | 8am - 7pm |
Wednesday | 10am - 5pm |
Thursday | 8am - 7pm |
Friday | 5pm - 7pm |
Saturday | 9am - 5pm |
Drop Us a Line